Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Organ Dysfunction Syndrome

Tundra lists 3 Organ Dysfunction Syndrome clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT05382065

Anemia and Duration of Mechanical Ventilation

In mechanically ventilated patients in intensive care unit, anemia is commonly seen and it is probably associated with adverse outcomes including mortality. We aim to investigate the impact of duration of anemia and the duration of mechanical ventilation as well as clinical outcomes in critically ill patients in intensive care unit who required ventilatory support \>96 hr.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-05

1 state

Anemia
Mechanical Ventilation
Critically Ill
+3
RECRUITING

NCT05623722

Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury

This study is a prospective, multicenter, parallel-group, open-label, randomized controlled clinical trial. Sepsis is defined as organ dysfunction induced by infections. And sepsis and gastrointestinal injury can be the leading cause for each other. Our previous study showed erector spinae plane block improved the organ dysfunctions in patients with AGI. The aim of the clinical trial is to investigate erector pinae plane block improves the organ dysfunction in septic patients with acute gastrointestinal injury.

Gender: All

Ages: 18 Years - Any

Updated: 2025-09-08

1 state

Sepsis
Acute Gastrointestinal Injury
Organ Dysfunction Syndrome
RECRUITING

NCT06473844

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Goal of this clinical trial is to examine the safety and efficacy of SGLT2 inhibitors on the clinical outcomes in patients with sepsis. Main study outcomes are as follows: (i) Primary objective is to examine the efficacy and safety of SGLT2 inhibitors on clinical outcomes in patients with sepsis. (ii) Secondary objective is to examine the effect of SGLT2 inhibitors on inflammatory markers in patients with sepsis.

Gender: All

Ages: 18 Years - Any

Updated: 2025-03-19

1 state

Sepsis
Inflammation
SGLT2 Inhibitors
+2